Imaging News and Research

RSS

Researchers use ATX-Red AR-2 as new imaging agent to illuminate tumors

Researchers from Echelon Biosciences, Inc. and collaborators from the University of Utah report the use of ATX-Red AR-2 as a new imaging agent that effectively illuminates tumors.

17 Dec 2013

Researchers confirm link between contrast agent and abnormalities on brain MRI

For the first time, researchers have confirmed an association between a common magnetic resonance imaging (MRI) contrast agent and abnormalities on brain MRI, according to a new study published online in the journal Radiology. The new study raises the possibility that a toxic component of the contrast agent may remain in the body long after administration.

17 Dec 2013

Alnylam initiates Phase II study with ALN-TTRsc for treatment of ATTR

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated a pilot Phase II study with ALN-TTRsc, a subcutaneously delivered RNAi therapeutic targeting the transthyretin gene in development for the treatment of TTR-mediated amyloidosis.

17 Dec 2013

New comprehensive edition for neurologists provides invaluable source of reference

A new comprehensive edition of a standard work, detailing and illustrating the organization, structure, function and connectivity of all individual brainstem nuclei. For neuroscientists and neurologists this atlas provides an invaluable and complete source of reference for both their scientific research and everyday clinical practice.

17 Dec 2013

Researchers identify potential biomarker to predict developmental problems in premature infants

Researchers have identified a potential biomarker for predicting whether a premature infant is at high risk for motor development problems, according to a study published online in the journal Radiology.

17 Dec 2013

New study aims to better understand brain aging and AD in adults with Down syndrome

To many, Down syndrome is a childhood condition. But improved health care means that individuals with DS now routinely reach age 50 or 60 years of age, sometimes beyond. However, if they live long enough, people with Down syndrome are almost certain to develop Alzheimer's disease.

17 Dec 2013

Researchers discover that unresponsive patients' brains may recognize photographs of their family, friends

Patients in a vegetative state are awake, breathe on their own, and seem to go in and out of sleep. But they do not respond to what is happening around them and exhibit no signs of conscious awareness. With communication impossible, friends and family are left wondering if the patients even know they are there.

17 Dec 2013

St. Joseph's Children's Hospital opens new Steinbrenner Children's Emergency/Trauma Center

St. Joseph's Children's Hospital in Tampa opened its new and expanded Steinbrenner Children's Emergency/Trauma Center Dec. 16, 2013. The hospital has the busiest children's emergency center in the region, and the larger, advanced facility will increase the community's access to the highest level of pediatric emergency care in the area.

16 Dec 2013

Study: Blue light proves to have powerful bacteria-killing ability

Blue light has proven to have powerful bacteria-killing ability in the laboratory. The potent antibacterial effects of irradiation using light in the blue spectra have now also been demonstrated in human and animal tissues. A series of groundbreaking articles that provide compelling evidence of this effect are published in Photomedicine and Laser Surgery, a peer-reviewed journal published by Mary Ann Liebert, Inc., publishers.

16 Dec 2013

Insomnia impact on sleepiness and vigilance performance differs by age

Insomnia may affect people in different ways as they age, results of a prospective, 10-year study suggest.

16 Dec 2013

New Opterra multipoint scanning confocal microscope from Bruker

Today at the 2013 American Society for Cell Biology Annual Meeting, Bruker introduced the Opterra Multipoint Scanning Confocal Microscope, which sets a new standard for integration of confocal imaging with photoactivation.

16 Dec 2013

Adding drug to presurgery chemotherapy improves results for women with triple-negative breast cancer

The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete testing in the trial. Adding the chemotherapy carboplatin and the molecularly targeted drug veliparib to standard presurgery chemotherapy improved outcomes for women with triple-negative breast cancer, according to results from the I-SPY 2 trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.

16 Dec 2013

Researchers identify new method to predict outcomes in heart failure patients

Researchers at the George Washington University School of Medicine and Health Sciences (SMHS) and Johns Hopkins University School of Medicine have identified a new method to determine whether a patient's heart will fail, which in the future may help physicians better treat patients and tailor therapeutic interventions.

16 Dec 2013

New technologies unveiled to provide expert care and streamline the process of treating breast cancer

Breast cancer patients are moms, wives, and caretakers. They are teachers, nurses, physicians and heads of industry. Today, more than ever before, women are delicately balancing the various roles of their lives. A breast cancer diagnosis and the treatment that follows is yet another challenge that unfortunately many women need to accommodate in their already busy schedules. That's why Jersey Shore University Medical Center, Ocean Medical Center and Riverview Medical Center offer technologies that provide expert care and streamline the process of treating breast cancer.

14 Dec 2013

Analysis provides first empirical evidence on how shared savings ACO model affect quality of care

Approximately 10 percent of Medicare spending is for cancer care, and Medicare spending is nearly four times higher for beneficiaries with cancer than in those without the disease. Little is known about how to curb spending growth while maintaining or improving quality of care for these high-risk, high-cost patients.

14 Dec 2013

Conventional echocardiography increases accuracy of pre-participation sports screening

Echocardiography with conventional M-mode and 2D modalities is a simple and cost effective way to increases the accuracy of pre-participation sports screening, according to research presented at EuroEcho-Imaging 2013 by Dr Alexander Kisko from Presov, Slovakia.

14 Dec 2013

Health Canada approves Genzyme's Lemtrada for adults with relapsing remitting multiple sclerosis

Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.

13 Dec 2013

Bioethics Commission releases ethical recommendations to manage incidental and secondary findings

Researchers conduct a memory study, scan a participant's brain, and find more than they bargain for: a tumor. What do the researchers owe the participant? What does the participant want to know?

13 Dec 2013

Transport of bacterial substrates through injectisome observed almost in real time

When attacking body cells, bacteria, such as salmonellae or Yersinia (plague pathogens), inject specific bacterial proteins through hollow, syringe-like structures - called injectisomes - into the host cells. These substances reprogram the cells and can thus overcome their defense. From then on, they can infiltrate the cells unhindered in large numbers, and trigger diseases such as typhus, plague, or cholera.

13 Dec 2013

Standardized research approaches needed for developing new treatments for neurofibromatosis

As potentially effective new treatments for neurofibromatosis (NF) are developed, standardized research approaches—including outcome measures specific to NF—are needed. The first report from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration has been published as a supplement to Neurology, the Official Journal of the American Academy of Neurology (AAN).

13 Dec 2013

Imaging News and Research

Researchers use ATX-Red AR-2 as new imaging agent to illuminate tumors

Researchers confirm link between contrast agent and abnormalities on brain MRI

Alnylam initiates Phase II study with ALN-TTRsc for treatment of ATTR

New comprehensive edition for neurologists provides invaluable source of reference

Researchers identify potential biomarker to predict developmental problems in premature infants

New study aims to better understand brain aging and AD in adults with Down syndrome

Researchers discover that unresponsive patients' brains may recognize photographs of their family, friends

St. Joseph's Children's Hospital opens new Steinbrenner Children's Emergency/Trauma Center

Study: Blue light proves to have powerful bacteria-killing ability

Insomnia impact on sleepiness and vigilance performance differs by age

New Opterra multipoint scanning confocal microscope from Bruker

Adding drug to presurgery chemotherapy improves results for women with triple-negative breast cancer

Researchers identify new method to predict outcomes in heart failure patients

New technologies unveiled to provide expert care and streamline the process of treating breast cancer

Analysis provides first empirical evidence on how shared savings ACO model affect quality of care

Conventional echocardiography increases accuracy of pre-participation sports screening

Health Canada approves Genzyme's Lemtrada for adults with relapsing remitting multiple sclerosis

Bioethics Commission releases ethical recommendations to manage incidental and secondary findings

Transport of bacterial substrates through injectisome observed almost in real time

Standardized research approaches needed for developing new treatments for neurofibromatosis

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News